Clinical trial for Prediabetes
Official title Study EHR Risk Stratification Tools
ClinicalTrials.gov ID: NCT06995378
What this study is testing
- What it's testing
- The study wants to see whether showing a "very low risk" label on lab results changes how older adults feel, their quality of life, and how they use health care.
- Who it's for
- Adults 65 years or older with a hemoglobin A1c between 5.7% and 6.0% who have a UCLA primary care provider.
- What's involved
- Participants will receive either normal lab messages or messages with a risk label. They will fill out two online surveys, one soon after the result appears in MyChart and another about 30 days later. Their health‑care use will also be tracked through de‑identified records.
- Time commitment
- The study lasts about a month, with two brief online surveys and ongoing tracking of health‑care use.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Age 65 years or older
- Hemoglobin A1c in the prediabetes range (5.7- but not including 6.0%)
You likely can't join if
- Have lab results outside the defined inclusion range
- No UCLA primary care provider
- Age \<65 years
- Eligibility for Surveys: All assigned by chance participants are eligible to receive study surveys.
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.